GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioRegenx Inc (OTCPK:BRGX) » Definitions » 3-Year FCF Growth Rate

BRGX (BioRegenx) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is BioRegenx 3-Year FCF Growth Rate?

BioRegenx's Free Cash Flow per Share for the three months ended in Sep. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Competitive Comparison of BioRegenx's 3-Year FCF Growth Rate

For the Health Information Services subindustry, BioRegenx's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioRegenx's 3-Year FCF Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioRegenx's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where BioRegenx's 3-Year FCF Growth Rate falls into.



BioRegenx 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


BioRegenx  (OTCPK:BRGX) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


BioRegenx 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of BioRegenx's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


BioRegenx Business Description

Traded in Other Exchanges
N/A
Address
7407 Ziegler Road, Chattanooga, TN, USA, 37421
BioRegenx Inc is redefining health intelligence with new patented technologies and artificial intelligence. Its specialize in developing intellectual property (IP) and are engaged in regenerative biotherapeutics, anti-aging, artificial intelligence (AI) for healthcare and bioinformatics for public and private transportation. The primary focus involves acquiring or developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing extensive datasets.

BioRegenx Headlines

From GuruFocus

Findit Inc Announces Investor Update

By ACCESSWIRE ACCESSWIRE 07-29-2022

Findit Inc Announces New Client � Rentalz.com

By ACCESSWIRE ACCESSWIRE 07-28-2022